T-CURX is a SME and Biotech spin-out from the partner UKW with expertise in pre-clinical, clinical and commercial development of ATMPs. T-CURX focuses on optimized CAR design to augment safety and efficacy, novel gene-transfer techniques to enhance genomic safety, accelerate & standardize manufacturing, technologies to enhance physician control over engineered T cells, and has a pipeline of CAR-T products in haematology and oncology. T-CURX is dedicated to augmenting the scientific, medical, regulatory and bioentrepreneurial environment for CAR-T & TCR-T in the EU, and to serve as a role model of successful Biotech SME in the business field of cell therapy.
Role within Project
- Support work in WP1 and WP2
- Represent biotech SMEs in imSAVAR
- Provide network to VC and the Biotech SME scene in the EU and US